| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 |
| filingDate |
2001-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e0c0d8d0773f2a59c394b872a8ca2403
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e847cbe90777a4d8d0112c3777a9c97
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7bd24c6a77bbce6077d7be79f6f7d4cc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_89b06c041c7ef88c0729cf72ac0e14a9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27d21a9919a0d5d26670835817a21855
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1385c52f6a1725ee17bebc5d39750cd4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4989452863575ebe8b65949b6c3e2113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b483356f18b5c8a3538a9beefd6730da
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d21f63b205a556c43f173d92e2039de7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_354040a66d164839e50ba9c5b491b11d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52522084d8780bc8a0938b2c0c7e38bb |
| publicationDate |
2003-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2003186332-A1 |
| titleOfInvention |
Neurotrophic factor expression-inducing agent |
| abstract |
The culture supernatant of COS cells expressing the PSEC56 gene was found to have a neurite extension effect. The main substance of the activity contained in this culture supernatant was revealed to be NGF. It was shown that PSEC56 can be utilized as a neurotrophic factor expression-inducing agent, and that the NGF induction system can be utilized for drug development against diseases of the nervous system. |
| priorityDate |
2000-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |